Adma Biologics Inc EPS Q / Q
¿Qué es el EPS Q / Q de Adma Biologics Inc?
El EPS Q / Q de Adma Biologics Inc es -38.46%
¿Cuál es la definición de EPS Q / Q?
La tasa de crecimiento trimestral del EPS, trimestre a trimestre , es el aumento del EPS de la compañía en los últimos 4 trimestres en comparación con el comportamiento de los 4 trimestres anteriores.
The earnings per share growth rate is an important factor for judging a company's value. EPS growth rate gives a good picture of the rate at which the company has grown its profitability in respect to the total number of shares. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS Q / Q de compañías en Sector Health Care en NASDAQ en comparadas con Adma Biologics Inc
¿Qué hace Adma Biologics Inc?
adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.
Empresas con eps q / q similar a Adma Biologics Inc
- Akzo Nobel NV tiene EPS Q / Q de -38.71%
- Aeglea BioTherapeutics Inc tiene EPS Q / Q de -38.71%
- InflaRx N.V tiene EPS Q / Q de -38.71%
- GE Aerospace tiene EPS Q / Q de -38.60%
- Semler Scientific tiene EPS Q / Q de -38.55%
- First Foundation Inc tiene EPS Q / Q de -38.55%
- Adma Biologics Inc tiene EPS Q / Q de -38.46%
- J&J Snack Foods tiene EPS Q / Q de -38.41%
- Stemline Therapeutics tiene EPS Q / Q de -38.36%
- Black Diamond Therapeutics Inc tiene EPS Q / Q de -38.14%
- AngloGold Ashanti Plc tiene EPS Q / Q de -38.10%
- Franklin Resources tiene EPS Q / Q de -38.10%
- Allena Pharmaceuticals Inc tiene EPS Q / Q de -38.10%